Novo Nordisk Oral GLP-1 Pipeline: Advances in Metabolic Therapeutics
Novo Nordisk leads the market in metabolic treatments through its range of injectable drugs. The manufacturer now develops oral…
-
-
Oral Wegovy Steps Into the Spotlight as Early Prescriptions Signal Strong Interest
Novo Nordisk has made an early mark in the U.S. weight-loss market with its new oral version of Wegovy,…
